Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02481921 · ClinicalTrials.gov registry record · NA

Group Medical Visits in Heart Failure

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
242
Enrollment target

NCT02481921: Completed NA study, sponsored by VA Office of Research and Development.

NCT02481921 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 242 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02481921, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
242 participants
Enrollment target

Study Summary

The primary goal of this proposal is to improve the quality of care and outcomes for patients discharged with heart failure using an innovative multidisciplinary group intervention approach. Heart failure is a complex chronic illness where comprehensive patient-centered care is difficult and resource intensive. One potential solution is to use shared medical appointments (SMA), where a group of patients with the same disease process shared the same medical or clinic appointment. This can be provided by a multi-disciplinary team of providers with expertise in nutrition, nursing, behavior and medication management join to manage heart failure. The investigators will enroll patients from Providence, Cleveland and Phoenix VA Hospitals who were within 12 weeks of discharge from a heart failure hospitalization and/or an outpatient encounter (clinic, emergent or urgent care) that required IV diuretic therapy. Patients were randomized them to receive SMA intervention or usual care. Results from this project are expected to add an innovative intervention that could improve outcomes important for both the patient and the VA: health status, hospitalizations, and mortality.

Interventions

  • BEHAVIORAL Group medical visits

Trial Details

FieldValue
Enrollment Target 242 participants
Start Date 2015-05-01
Est. Completion 2021-12-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02481921

The ClinicalTrials.gov registry entry for NCT02481921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Group medical visits is the first listed.

NCT02481921 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02481921 about?

NCT02481921 is a clinical study titled "Group Medical Visits in Heart Failure". The primary goal of this proposal is to improve the quality of care and outcomes for patients discharged with heart failure using an innovative multidisciplinary group intervention approach. Heart failure is a complex chronic illness where comprehensive patient-centered care is difficult and resourc...

What is the current status of trial NCT02481921?

This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2015-05-01. Estimated completion is 2021-12-31.

What interventions are being tested in trial NCT02481921?

The interventions under investigation include: Group medical visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT02481921?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.